Literature DB >> 8801169

RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells.

V Horn1, S Minucci, V V Ogryzko, E D Adamson, B H Howard, A A Levin, K Ozato.   

Abstract

Retinoids cause differentiation in embryonal carcinoma (EC) cells, thus mimicking events in mammalian development. Here, we show that retinoids also cause apoptosis in P19 EC cells. Characteristic DNA fragmentation was observed within 36 h after addition of retinoic acid (RA). Synthetic retinoids that are selective for RA receptors (RAR) were also effective in inducing apoptosis, whereas RXR selective ligands were without effect. The combination of RAR and RXR ligands resulted in a synergistic increase in apoptotic cell death. As with apoptosis, neuronal differentiation of P19 cells was synergistically induced by the combination of RAR and RXR ligands. Data obtained with an RAR antagonist and with P19 cells carrying a dominant negative RXR indicate that the two processes are receptor mediated. Together, our results indicate that retinoid-induced apoptosis and neuronal differentiation are closely coupled, and that both RAR and RXR play a role in these processes as active receptors for their respective ligands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8801169     DOI: 10.1096/fasebj.10.9.8801169

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

1.  A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition.

Authors:  A Dey; J Ellenberg; A Farina; A E Coleman; T Maruyama; S Sciortino; J Lippincott-Schwartz; K Ozato
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells.

Authors:  S Minucci; V Horn; N Bhattacharyya; V Russanova; V V Ogryzko; L Gabriele; B H Howard; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Correct cell- and differentiation-specific expression of a murine alpha 1 (I) collagen minigene in vitro differentiating embryonal carcinoma cells.

Authors:  K Rhodes; K Hall; K E Lee; H Razzaghi; M Breindl
Journal:  Gene Expr       Date:  1996

4.  Retinoid-induced chromatin structure alterations in the retinoic acid receptor beta2 promoter.

Authors:  N Bhattacharyya; A Dey; S Minucci; A Zimmer; S John; G Hager; K Ozato
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

5.  Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs.

Authors:  G Xu; M Redard; G Gabbiani; P Neuville
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

6.  4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals.

Authors:  K Murakami; T Matsuura; M Sano; A Hashimoto; K Yonekura; R Sakukawa; Y Yamada; I Saiki
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

Review 7.  SIRT1 and Neural Cell Fate Determination.

Authors:  Yulong Cai; Le Xu; Haiwei Xu; Xiaotang Fan
Journal:  Mol Neurobiol       Date:  2015-04-08       Impact factor: 5.590

8.  Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes.

Authors:  Yang-Yi Fan; Thomas E Spencer; Naisyin Wang; Mary P Moyer; Robert S Chapkin
Journal:  Carcinogenesis       Date:  2003-07-04       Impact factor: 4.944

9.  Cellular distribution of retinoic acid receptor-alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin: comparison with estrogen receptor status.

Authors:  C D Katsetos; I Stadnicka; J C Boyd; H Ehya; S Zheng; C M Soprano; H S Cooper; A S Patchefsky; D R Soprano; K J Soprano
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

10.  Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression.

Authors:  Joshua P Klopper; Vibha Sharma; Andrew Berenz; William R Hays; Michele Loi; Umarani Pugazhenthi; Sherif Said; Bryan R Haugen
Journal:  Mol Cancer       Date:  2009-03-06       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.